|
1
|
Morris LG, Tuttle RM and Davies L:
Changing trends in the incidence of thyroid cancer in the United
States. JAMA Otolaryngol Head Neck Surg. 142:709–711. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xing M, Alzahrani AS, Carson KA, Shong YK,
Kim TY, Viola D, Elisei R, Bendlová B, Yip L, Mian C, et al:
Association between BRAF V600E mutation and recurrence of papillary
thyroid cancer. J Clin Oncol. 33:42–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carracedo A, Cantley LC and Pandolfi PP:
Cancer metabolism: Fatty acid oxidation in the limelight. Nat Rev
Cancer. 13:227–232. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Santos CR and Schulze A: Lipid metabolism
in cancer. FEBS J. 279:2610–2623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baenke F, Peck B, Miess H and Schulze A:
Hooked on fat: The role of lipid synthesis in cancer metabolism and
tumour development. Dis Model Mech. 6:1353–1363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
von Roemeling CA, Marlow LA, Pinkerton AB,
Crist A, Miller J, Tun HW, Smallridge RC and Copland JA: Aberrant
lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl
CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol
Metab. 100:E697–E709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uddin S, Siraj AK, Al-Rasheed M, Ahmed M,
Bu R, Myers JN, Al-Nuaim A, Al-Sobhi S, Al-Dayel F, Bavi P, et al:
Fatty acid synthase and AKT pathway signaling in a subset of
papillary thyroid cancers. J Clin Endocrinol Metab. 93:4088–4097.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Nie F, Wang S and Li L: Histone H4
Lys 20 monomethylation by histone methylase SET8 mediates Wnt
target gene activation. Proc Natl Acad Sci USA. 108:3116–3123.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abbas T, Shibata E, Park J, Jha S, Karnani
N and Dutta A: CRL4Cdt2 regulates cell proliferation and
histone gene expression by targeting PR-Set7/Set8 for degradation.
Mol Cell. 40:9–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Centore RC, Havens CG, Manning AL, Li JM,
Flynn RL, Tse A, Jin J, Dyson NJ, Walter JC and Zou L:
CRL4Cdt2-mediated destruction of the histone
methyltransferase Set8 prevents premature chromatin compaction in S
phase. Mol Cell. 40:22–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Houston SI, McManus KJ, Adams MM, Sims JK,
Carpenter PB, Hendzel MJ and Rice JC: Catalytic function of the
PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for
mitotic entry and genomic stability. J Biol Chem. 283:19478–19488.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oda H, Hübner MR, Beck DB, Vermeulen M,
Hurwitz J, Spector DL and Reinberg D: Regulation of the histone H4
monomethylase PR-Set7 by CRL4Cdt2-mediated
PCNA-dependent degradation during DNA damage. Mol Cell. 40:364–376.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu S, Wang W, Kong X, Congdon LM, Yokomori
K, Kirschner MW and Rice JC: Dynamic regulation of the PR-Set7
histone methyltransferase is required for normal cell cycle
progression. Genes Dev. 24:2531–2542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi X, Kachirskaia I, Yamaguchi H, West
LE, Wen H, Wang EW, Dutta S, Appella E and Gozani O: Modulation of
p53 function by SET8-mediated methylation at lysine 382. Mol Cell.
27:636–646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang F, Sun L, Li Q, Han X, Lei L, Zhang H
and Shang Y: SET8 promotes epithelial-mesenchymal transition and
confers TWIST dual transcriptional activities. EMBO J. 31:110–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liao T, Wen D, Ma B, Hu JQ, Qu N, Shi RL,
Liu L, Guan Q, Li DS and Ji QH: Yes-associated protein 1 promotes
papillary thyroid cancer cell proliferation by activating the
ERK/MAPK signaling pathway. Oncotarget. 8:11719–11728. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Dai X, Zhong J, Inuzuka H, Wan L,
Li X, Wang L, Ye X, Sun L, Gao D, et al: SCFβ−TRCP
promotes cell growth by targeting PR-Set7/Set8 for degradation. Nat
Commun. 6:101852015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Swain JF, Dinler G, Sivendran R,
Montgomery DL, Stotz M and Gierasch LM: Hsp70 chaperone ligands
control domain association via an allosteric mechanism mediated by
the interdomain linker. Mol Cell. 26:27–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cook KL, Soto-Pantoja DR, Clarke PA, Cruz
MI, Zwart A, Wärri A, Hilakivi-Clarke L, Roberts DD and Clarke R:
Endoplasmic reticulum stress protein GRP78 modulates lipid
metabolism to control drug sensitivity and antitumor immunity in
breast cancer. Cancer Res. 76:5657–5670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sorrentino G, Ruggeri N, Specchia V,
Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio
R, Piazza S, et al: Metabolic control of YAP and TAZ by the
mevalonate pathway. Nat Cell Biol. 16:357–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Freed-Pastor WA, Mizuno H, Zhao X,
Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li
W, Polotskaia A, et al: Mutant p53 disrupts mammary tissue
architecture via the mevalonate pathway. Cell. 148:244–258. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X, Wu JB, Chung LW and Huang WC:
Anti-cancer efficacy of SREBP inhibitor, alone or in combination
with docetaxel, in prostate cancer harboring p53 mutations.
Oncotarget. 6:41018–41032. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Horton JD, Goldstein JL and Brown MS:
SREBPs: Activators of the complete program of cholesterol and fatty
acid synthesis in the liver. J Clin Invest. 109:1125–1131. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dulev S, Tkach J, Lin S and Batada NN:
SET8 methyltransferase activity during the DNA double-strand break
response is required for recruitment of 53BP1. EMBO Rep.
15:1163–1174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu B, Zhang X, Song F, Liu Q, Dai H,
Zheng H, Cui P, Zhang L, Zhang W and Chen K: A functional single
nucleotide polymorphism of SET8 is prognostic for breast cancer.
Oncotarget. 7:34277–34287. 2016.PubMed/NCBI
|
|
26
|
Hou L, Li Q, Yu Y, Li M and Zhang D: SET8
induces epithelial mesenchymal transition and enhances prostate
cancer cell metastasis by cooperating with ZEB1. Mol Med Rep.
13:1681–1688. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi XL, Guo ZJ, Wang XL, Liu XL and Shi
GF: SET8 expression is associated with overall survival in gastric
cancer. Genet Mol Res. 14:15609–15615. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aylon Y and Oren M: The Hippo pathway, p53
and cholesterol. Cell Cycle. 15:2248–2255. 2016. View Article : Google Scholar : PubMed/NCBI
|
